¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

°Ç±¹´ëÇб³º´¿ø ¿µ»óÀÇÇаú 2019 APECS (Advances in Peripheral EndovasCular Strategies) : 2019-11-24

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
°Ç±¹´ëÇб³º´¿ø ¿µ»óÀÇÇаú 2019 APECS (Advances in Peripheral EndovasCular Strategies) : 2019-11-24
±³À°ÀÏÀÚ : 2019-11-24
±³À°Àå¼Ò : °Ç±¹´ëÇб³º´¿ø ´ë°­´ç(B3)  
±³À°ÁÖÁ¦ : 2019 APECS (Advances in Peripheral EndovasCular Strategies)      
ÁÖÃÖ±â°ü : °Ç±¹´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¿µ»óÀÇÇаú  
´ã´çÀÚ : ÇÔ»óÇù
¿¬¶ôó : 02-3144-2227  
À̸ÞÀÏ : apecsmeeting@gmail.com      
±³À°Á¾·ù : ¿µ»óÀÇÇаú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 30,000¿ø      
ºñ°í »çÀüµî·Ï½Ã µî·Ïºñ ¹«·á ÇöÀåµî·Ï½Ã Àü¹®ÀÇ:3¸¸¿ø, ±âŸ:1¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-24  09:00~09:10 How to assess treatment result for CVI?  Á¤ÇõÀç(ºÎ»êÀÇ´ë ¾ç»ê) 
±³À°½Ã°£ 11-24  09:10~09:20 Things you need to know when you begin US examination  ÀåÀϼö(¼ö¿µ»óÀÇÇÐ) 
±³À°½Ã°£ 11-24  09:20~09:50 Live Case 1. Thermal ablation  ¹Ú»ó¿ì,ȲÁøÈ£,±Ç¿ë¿ø,¹ÎÁö¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-24  09:50~10:00 What unique refluxes and unusual anatomical variations should we know during ultrasound?  ±è¹ÌÇü(°¡Å縯ÀÇ´ë ÀºÆò) 
±³À°½Ã°£ 11-24  10:00~10:10 Important meanings of US control panel: How to use them?  À¯ÈçÁ¦(ij³íÄÚ¸®¾Æ) 
±³À°½Ã°£ 11-24  10:10~10:20 Venous pain: How to differentiate and how to manage it?  ³ëȯ±Ô(ÇÏÆ®À£ÀÇ¿ø) 
±³À°½Ã°£ 11-24  10:20~10:30 APECS meets IVDT symposium : What venous issues were hot in the past IVDT?  Á¶ÁøÇö(°æÈñÀÇ´ë) 
±³À°½Ã°£ 11-24  10:30~10:50 Coffee break  () 
±³À°½Ã°£ 11-24  10:50~11:20 Live Case 2. Thermal ablation  ¹Ú»ó¿ì,ȲÁøÈ£,±Ç¿ë¿ø,¹ÎÁö¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-24  11:20~11:30 How to make standardization for EVLT regarding wavelength, LEED, and fiber tips?  À̰溹(¼­¿ïÀÇ·á¿ø) 
±³À°½Ã°£ 11-24  11:30~11:40 Can 1940nm laser overcome shortcomings of previous endovenous lasers?  ¹ÚÀμö(ÂüÇÏÁö¿Ü°ú) 
±³À°½Ã°£ 11-24  11:40~11:50 New radiofrequency catheter came up. What is different?  ¹Ú»ó¿ì(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-24  11:50~12:20 Live Case 3. Venaseal  ¹Ú»ó¿ì,ȲÁøÈ£,±Ç¿ë¿ø,¹ÎÁö¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-24  12:20~12:30 Do we still need to believe in the superiority of radiofrequency over EVLT since ¡°RECOVERY¡± study?  Â÷´ë¿ø(»ï¼ºÈäºÎ¿Ü°úÀÇ¿ø) 
½Ä»ç 11-24  12:30~13:10 Lunch  () 
±³À°½Ã°£ 11-24  13:10~13:50 Special Lecture: 2020³â °Ç°­º¸Çè Á¤Ã¥¹æÇâ (ÇÏÁöÁ¤¸Æ·ù¿Í Ç÷°üÃÊÀ½ÆÄ ÁúÀÇ ÀÀ´ä Æ÷ÇÔ)  ÀÌÁß±Ô(º¸°Çº¹ÁöºÎ º¸Çè±Þ¿©°ú) 
±³À°½Ã°£ 11-24  13:50~14:00 Hydrophilic guide wire is necessary to increase technical success of endovenous treatment?  È²ÁøÈ£(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-24  14:00~14:10 What hurdles do we tend to face during VenaSeal treatment? How to overcome them?  ±è°Ç¿ì(¹ÎÆ®º´¿ø) 
±³À°½Ã°£ 11-24  14:10~14:20 How to reduce and manage phlebitis or any other complications after VenaSeal  À̱æ¼ö(Á¦ÁÖ¼öÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11-24  14:20~14:30 Do we need to make even distribution of sclerosant during MOCA? How to increase technical or clinical success rate?  À̽Âö(ÆíÇÑÇÏÁöÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11-24  14:30~15:00 Live Case 4. MOCA  ¹Ú»ó¿ì,ȲÁøÈ£,±Ç¿ë¿ø,¹ÎÁö¿µ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-24  15:00~15:10 What are the limitations or contraindications for MOCA?  °øÁØÇõ(¸ÞµðÇ÷º½º¼¼Á¾º´¿ø) 
±³À°½Ã°£ 11-24  15:10~15:20 How to select endovenous devices according to lesion characteristics  ±èÇâ°æ(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 11-24  15:20~15:30 Coffee break  () 
±³À°½Ã°£ 11-24  15:30~15:40 How to reduce infection related to PICC  ¿ÀÇàÁø(ÀÎÁ¦ÀÇ´ë ¼­¿ï) 
±³À°½Ã°£ 11-24  15:40~15:50 What are differences among many PICCs in Korea? What do we need to consider before picking up?  ¼Û¸í±Ô(°í·ÁÀÇ´ë ±¸·Î) 
±³À°½Ã°£ 11-24  15:50~16:00 Is subclavian vein really thrombogenic? Do we need to avoid it?  ±è¿ëÀç(¼øõÇâÀÇ´ë ¼­¿ï) 
±³À°½Ã°£ 11-24  16:00~16:10 What is the preliminary result of multicenter retrospective study regarding risk factors for PICC associated complications?  ±èÀÀÅÂ(ÇѾç´ëÇб³ ±¸¸®) 
±³À°½Ã°£ 11-24  16:10~16:20 No route in limb for hemodialysis: Hero and Surfacer can give us the solution.  ¾ç½ÂºÎ(¼øõÇâÀÇ´ë ±¸¹Ì) 
±³À°½Ã°£ 11-24  16:20~16:30 No route in limb for hemodialysis: Transrenal insertion of Perm-cath may serve as an alternative route  ½ÅÁöÈÆ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-24  16:30~16:40 Repair vs. exchange of malfunctioning perm-cath: Which one is better?  Á¶¼º±â(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-24  16:40~16:45 New PICC catheter development: KUH research result  ¹ÎÁö¿µ(°Ç±¹ÀÇ´ë) 
Åä·Ð 11-24  16:45~16:55 Discussion  () 
±âŸ 11-24  16:55~17:00 Closing Remark  ¹Ú»ó¿ì(°Ç±¹ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" °Ç±¹´ëÇб³º´¿ø ¿µ»óÀÇÇаú 2019 APECS (Advances in Peripheral EndovasCular Strategies) : 2019-11-24""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼­¿ï´ëº´¿ø 2019³âµµ ´ëÇѳúÀüÁõÇÐȸ °³¿øÀÇ ¿¬¼ö°­Á : 2019-11-24
´ÙÀ½±Û »ï¼º¼­¿ïº´¿ø 2019 ÀÌ°úÇÐ Live Surgery ¹× ½ÅÀÇ·á±â¼ú ¼¼¹Ì³ª : 2019-11-24
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21135 °æ±â Á¦10Â÷ ¿¬¼¼ÀÇ´ë ¼Ò¾Æû¼Ò³â°ú Áö¿ªÀÇ»ç Áý´ãȸ : 2024-07-31 0 37 2024-06-19
21134 °æ±â 2024 Çѱ¹¼ö¸éÇÐȸ ÇÏ°èÇмú´ëȸ : 2024-07-26 0 49 2024-06-19
21133 ¼­¿ï 2024³â ´ëÇÑÇǺη¹ÀÌÀúÇÐȸ Á¦25ȸ Çмú´ëȸ : 2024-07-21 0 39 2024-06-19
21132 ¼­¿ï ´ëÇÑÀÓ»ó¾Ï´ë»çÀÇÇÐȸ 2024³â Ãß°èÇмú´ëȸ IVC¿Í Detox : 2024-07-21 0 35 2024-06-19
21131 ´ë±¸ ´ë±¸°æºÏ³»°úÇÐȸ 2024³â Á¤±âÇмú´ëȸ : 2024-07-21 0 35 2024-06-19
21130 Á¦ÁÖ Á¦13ȸ ´ëÇѳ»ºÐºñÇÐȸ Á¦ÁÖÁöȸ ¿¬¼ö°­Á : 2024-07-20 0 20 2024-06-19
21129 ±¤ÁÖ Á¦225Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ ±¤ÁÖÀü³²Áöȸ ¿¬¼ö°­Á : 2024-07-16 0 24 2024-06-19
21128 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ Á¦3ȸ ÃÊÀ½ÆÄ ½ÇÀü ¾ÆÄ«µ¥¹Ì : 2024-07-15 0 42 2024-06-19
21127 ¼­¿ï 2024 ¼¼ºê¶õ½ºº´¿ø ¼ÒÈ­±âÇÐ ¿¬¼ö°­Á : 2024-07-14 0 38 2024-06-19
21126 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑôÃß¿µ»óÀÇÇÐȸ Á¤±â¿¬¼ö°­Á : 2024-07-14 0 30 2024-06-19
21125 ¼­¿ï Á¦29Â÷ Ưº°¿¬¼ö°­Á – »êºÎÀΰú Áúȯ óġÀÇ ÃֽŠÁö°ß : 2024-07-14 0 26 2024-06-19
21124 °­¿ø 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ °­¿øÁöȸ ¿¬¼ö°­Á : 2024-07-14 0 30 2024-06-19
21123 ¼­¿ï 2024³â ´ëÇѹ̼¼¼ö¼úÇÐȸ Ãá°è ¹Ì¼¼¼ö¼ú ¿öÅ©¼ó : 2024-07-14 0 28 2024-06-19
21122 ¼­¿ï Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(2ÀÏÂ÷) : 2024-07-14 0 25 2024-06-19
21121 ¼­¿ï Á¦8ȸ ÀüÀÓÀÇ Àü°øÀÇ °³¿øÀǸ¦ À§ÇÑ °£Áúȯ ¿¬¼ö°­Á : 2024-07-14 0 49 2024-06-19
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷